Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Aug;31(4):1233-1236.
doi: 10.19746/j.cnki.issn.1009-2137.2023.04.047.

[The Latest Research Progress of Mesenchymal Stem Cells Derived from Multiple Myeloma Patients --Review]

[Article in Chinese]
Affiliations
Review

[The Latest Research Progress of Mesenchymal Stem Cells Derived from Multiple Myeloma Patients --Review]

[Article in Chinese]
Xiao-Sui Ling et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023 Aug.

Abstract

Multiple myeloma (MM) is a malignant proliferative disease of plasma cells. Bone marrow mesenchymal stem cells (MSC) play an important role in the progression of MM. Compared with normal donor derived MSC (ND-MSC), MM patients derived MSC (MM-MSC) exhibit abnormalities in genes, signaling pathways, protein expression levels and cytokines secreted by themselves. Moreover, the exosomes of MM-MSC can interact with the bone marrow microenvironment. The above reasons can lead to MM cell proliferation, chemoresistance, impaired osteogenic differentiation of MM-MSC, and affect the immunomodulatory capacity of MM patients. In order to further understand the pathogenesis and related influencing factors of MM, this paper reviews the latest research progress of MM-MSC.

题目: 多发性骨髓瘤患者来源间充质干细胞的最新研究进展.

摘要: .多发性骨髓瘤(MM)是一种浆细胞恶性增殖性疾病,骨髓间充质干细胞(MSC)在MM的疾病进展过程中发挥着重要作用。与正常供者来源MSC(ND-MSC)相比,MM来源MSC(MM-MSC)表现出基因、信号通路、蛋白质表达水平和自身分泌细胞因子的异常,且其外泌体与骨髓微环境相互影响,以上原因可导致MM细胞增殖、化疗耐药、MM-MSC成骨分化障碍,并影响MM患者的免疫调节能力。为进一步了解MM的发病机理及相关影响因素,本文针对MM-MSC的最新研究进展作一综述。.

Keywords: bone marrow microenvironment; cytokines; mesenchymal stem cells; multiple myeloma; signaling pathways.

PubMed Disclaimer

Similar articles

LinkOut - more resources